Synthesizing our understanding of the biology of SMAD4 in both the BMP and Wnt pathways, and with the findings from our previous studies, we hypothesized that a SMAD4‐modulated gene profile could help identify patients with high‐risk CRC and worse disease‐free survival. The gene discussed is SMAD4; the disease is colorectal carcinoma.